FI873350A0 - Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat

Info

Publication number
FI873350A0
FI873350A0 FI873350A FI873350A FI873350A0 FI 873350 A0 FI873350 A0 FI 873350A0 FI 873350 A FI873350 A FI 873350A FI 873350 A FI873350 A FI 873350A FI 873350 A0 FI873350 A0 FI 873350A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
FI873350A
Other languages
English (en)
Finnish (fi)
Other versions
FI91634B (sv
FI91634C (sv
FI873350A (sv
Inventor
Alexander Lawrence Johnson
Petrus Bernardus Ma Timmermans
Philip Ma
Ruth Richmond Wexler
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of FI873350A0 publication Critical patent/FI873350A0/sv
Publication of FI873350A publication Critical patent/FI873350A/sv
Publication of FI91634B publication Critical patent/FI91634B/sv
Application granted granted Critical
Publication of FI91634C publication Critical patent/FI91634C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI873350A 1986-08-04 1987-08-03 Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat FI91634C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89229386A 1986-08-04 1986-08-04
US89229386 1986-08-04
US07/064,361 US4868181A (en) 1986-08-04 1987-06-30 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
US6436187 1987-06-30

Publications (4)

Publication Number Publication Date
FI873350A0 true FI873350A0 (sv) 1987-08-03
FI873350A FI873350A (sv) 1988-02-05
FI91634B FI91634B (sv) 1994-04-15
FI91634C FI91634C (sv) 1994-07-25

Family

ID=26744430

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873350A FI91634C (sv) 1986-08-04 1987-08-03 Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat

Country Status (12)

Country Link
US (1) US4868181A (sv)
EP (1) EP0255710A3 (sv)
KR (1) KR930004648B1 (sv)
AU (1) AU617650B2 (sv)
DK (1) DK403287A (sv)
FI (1) FI91634C (sv)
HU (1) HU201925B (sv)
IL (1) IL83413A0 (sv)
NO (1) NO171909C (sv)
NZ (1) NZ221284A (sv)
PT (1) PT85483B (sv)
SU (3) SU1607687A3 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
JPS63112560A (ja) * 1986-10-29 1988-05-17 Green Cross Corp:The ジヒドロピリジン誘導体
DE3711991A1 (de) * 1987-04-09 1988-10-20 Bayer Ag Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3737341A1 (de) * 1987-11-04 1989-05-18 Bayer Ag Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3737340A1 (de) * 1987-11-04 1989-05-24 Bayer Ag Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US5106845A (en) * 1990-01-10 1992-04-21 Merrell Dow Pharmaceuticals Inc. Calcium antagonists
CA2009542C (en) * 1989-02-10 2000-03-14 Albert A. Carr Cyclic guanidines as calcium antagonists
US5166148A (en) * 1990-07-09 1992-11-24 The Du Pont Merck Pharmaceutical Company 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
IL109220A0 (en) * 1993-04-05 1994-07-31 Synaptic Pharma Corp Dihydropyridines and new uses thereof
US6211198B1 (en) 1993-04-05 2001-04-03 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
US5767131A (en) * 1993-04-05 1998-06-16 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
DE4410822A1 (de) * 1994-03-24 1995-09-28 Schering Ag Neue Piperidin-Derivate
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
AU6229099A (en) * 1998-10-23 2000-05-15 Ajinomoto Co., Inc. Dihydropyridine derivatives and drug compositions containing the same
EP2925739A4 (en) * 2012-11-28 2016-07-27 Stichting Dienst Landbouwkundi SUBSTITUTED DIHYDROPYRTOINS FOR PLANTS WITH SOMATIC EMBRYOGENESIS I

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS57171968A (en) * 1981-04-17 1982-10-22 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
DE3377352D1 (en) * 1982-06-03 1988-08-18 Pierrel Spa Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them
WO1985000169A1 (en) * 1983-06-21 1985-01-17 Sandoz Ag 1,4-dihydropyridine derivatives, production thereof and pharmaceutical preparations containing them
DE3326384A1 (de) * 1983-07-22 1985-01-31 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
DE3339861A1 (de) * 1983-11-04 1985-05-15 Bayer Ag, 5090 Leverkusen Arzneizubereitung enthaltend dihydropyridine
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities
JPS6191185A (ja) * 1984-10-11 1986-05-09 Sumitomo Seiyaku Kk 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体
AU5312086A (en) * 1984-12-21 1986-07-22 Byk Gulden Lomberg Chemische Fabrik Gmbh New piperazine derivatives
GB8503427D0 (en) * 1985-02-11 1985-03-13 Ici Plc Basic compounds
DE3521761A1 (de) * 1985-06-19 1987-01-02 Bayer Ag Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
EP0222702A3 (de) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Basische Carbonylverbindungen
DE3600596A1 (de) * 1986-01-11 1987-07-16 Bayer Ag 4-aminoaryldihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JP2742074B2 (ja) * 1988-11-30 1998-04-22 マツダ株式会社 浸炭炉

Also Published As

Publication number Publication date
NZ221284A (en) 1989-12-21
KR880002827A (ko) 1988-05-11
SU1607687A3 (ru) 1990-11-15
HU201925B (en) 1991-01-28
NO171909B (no) 1993-02-08
SU1609452A3 (ru) 1990-11-23
DK403287D0 (da) 1987-08-03
NO171909C (no) 1993-05-19
AU617650B2 (en) 1991-12-05
PT85483A (en) 1987-09-01
HUT46907A (en) 1988-12-28
NO873240L (no) 1988-02-05
US4868181A (en) 1989-09-19
FI91634B (sv) 1994-04-15
IL83413A0 (en) 1988-01-31
AU7650387A (en) 1988-02-11
EP0255710A2 (en) 1988-02-10
PT85483B (pt) 1990-06-29
NO873240D0 (no) 1987-08-03
SU1650011A3 (ru) 1991-05-15
FI91634C (sv) 1994-07-25
EP0255710A3 (en) 1989-01-04
FI873350A (sv) 1988-02-05
KR930004648B1 (ko) 1993-06-02
DK403287A (da) 1988-02-05

Similar Documents

Publication Publication Date Title
FI890282A0 (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI874459A (sv) Förfarande för framställning av terapeutiskt användbara piperidinderivat
FI104170B1 (sv) Förfarande för framställning av terapeutiskt användning 3-aminopyrazolderivat
FI871041A0 (sv) Förfarande för framställning av terapeutiskt användbara 3,5-disubstituerade pyrokatekolderivat
FI890245A0 (sv) Förfarande för framställning av terapeutiskt användbara 1,4-disubstituerade piperidinylderivat
FI873350A0 (sv) Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat
FI92696C (sv) Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat
FI872517A0 (sv) Förfarande för framställning av terapeutiskt användbara makrolidföreningar
FI891339A0 (sv) Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat
FI883672A (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI880467A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
FI93444B (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
PL268618A1 (en) The method of manufacture of 1,4-dihydropyridine derivatives
FI893003A (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat
FI92064C (sv) Förfarande för framställning av terapeutiskt användbara N-bensopyranyllaktamer
PT84959A (en) Process for the preparation of novel 1,4-dihydropyridines
FI884473A (sv) Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat
FI892420A (sv) Förfarande för framställning av terapeutiskt användbara 2-aminoetanolderivat
PT88158A (pt) Process for the preparation of a novel diosmin derivative
FI891111A (sv) Förfarande för framställning av 1,4-dihydropyridinderivat
EP0371492A3 (en) Process for the preparation of 1,4-dihydropyridine derivatives
FI93216C (sv) Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat
FI893434A (sv) Förfarande för framställning av nya terapeutiskt användbara cykloalkyltiazolderivat
FI93118B (sv) Förfarande för framställning av nya terapeutiskt användbara 1,4-diazepinderivat
FI92393B (sv) Förfarande för framställning av 1,5-bensotiazepinderivat

Legal Events

Date Code Title Description
BB Publication of examined application
FD Application lapsed
MM Patent lapsed
MM Patent lapsed

Owner name: THE DU PONT MERCK PHARMACEUTICAL COMPANY